BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23361403)

  • 1. Combinatorial tuning of peptidic drug candidates: high-affinity matriptase inhibitors through incremental structure-guided optimization.
    Fittler H; Avrutina O; Glotzbach B; Empting M; Kolmar H
    Org Biomol Chem; 2013 Mar; 11(11):1848-57. PubMed ID: 23361403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent inhibitors of human matriptase-1 based on the scaffold of sunflower trypsin inhibitor.
    Fittler H; Avrutina O; Empting M; Kolmar H
    J Pept Sci; 2014 Jun; 20(6):415-20. PubMed ID: 24723440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase.
    Jiang S; Li P; Lee SL; Lin CY; Long YQ; Johnson MD; Dickson RB; Roller PP
    Org Lett; 2007 Jan; 9(1):9-12. PubMed ID: 17192072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Between two worlds: a comparative study on in vitro and in silico inhibition of trypsin and matriptase by redox-stable SFTI-1 variants at near physiological pH.
    Avrutina O; Fittler H; Glotzbach B; Kolmar H; Empting M
    Org Biomol Chem; 2012 Oct; 10(38):7753-62. PubMed ID: 22903577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity cyclic peptide matriptase inhibitors.
    Quimbar P; Malik U; Sommerhoff CP; Kaas Q; Chan LY; Huang YH; Grundhuber M; Dunse K; Craik DJ; Anderson MA; Daly NL
    J Biol Chem; 2013 May; 288(19):13885-96. PubMed ID: 23548907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1.
    Li P; Jiang S; Lee SL; Lin CY; Johnson MD; Dickson RB; Michejda CJ; Roller PP
    J Med Chem; 2007 Nov; 50(24):5976-83. PubMed ID: 17985858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus.
    Frecer V; Kabelác M; De Nardi P; Pricl S; Miertus S
    J Mol Graph Model; 2004 Jan; 22(3):209-20. PubMed ID: 14629979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of the sunflower derived trypsin inhibitor as a potent inhibitor of the type II transmembrane serine protease, matriptase.
    Long YQ; Lee SL; Lin CY; Enyedy IJ; Wang S; Li P; Dickson RB; Roller PP
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2515-9. PubMed ID: 11549459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and chemical syntheses of potent matriptase-2 inhibitors based on trypsin inhibitor SFTI-1 isolated from sunflower seeds.
    Gitlin-Domagalska A; Dębowski D; Łęgowska A; Stirnberg M; Okońska J; Gütschow M; Rolka K
    Biopolymers; 2017 Nov; 108(6):. PubMed ID: 28555756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1.
    de Veer SJ; Li CY; Swedberg JE; Schroeder CI; Craik DJ
    Eur J Med Chem; 2018 Jul; 155():695-704. PubMed ID: 29936356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of Matriptase-2 Based on the Trypsin Inhibitor SFTI-1.
    Gitlin A; Dębowski D; Karna N; Łęgowska A; Stirnberg M; Gütschow M; Rolka K
    Chembiochem; 2015 Jul; 16(11):1601-7. PubMed ID: 25999208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of serine proteinase inhibitors by combinatorial chemistry using trypsin inhibitor SFTI-1 as a starting structure.
    Zabłotna E; Jaśkiewicz A; Łegowska A; Miecznikowska H; Lesner A; Rolka K
    J Pept Sci; 2007 Nov; 13(11):749-55. PubMed ID: 17828796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
    Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.
    Goswami R; Mukherjee S; Ghadiyaram C; Wohlfahrt G; Sistla RK; Nagaraj J; Satyam LK; Subbarao K; Palakurthy RK; Gopinath S; Krishnamurthy NR; Ikonen T; Moilanen A; Subramanya HS; Kallio P; Ramachandra M
    Bioorg Med Chem; 2014 Jun; 22(12):3187-203. PubMed ID: 24794746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase.
    Steinmetzer T; Schweinitz A; Stürzebecher A; Dönnecke D; Uhland K; Schuster O; Steinmetzer P; Müller F; Friedrich R; Than ME; Bode W; Stürzebecher J
    J Med Chem; 2006 Jul; 49(14):4116-26. PubMed ID: 16821772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of alpha-hydroxymethyamino acid residues in substrate specificity P1 position of trypsin inhibitor SFTI-1 from sunflower seeds retains its activity.
    Zabłotna E; Kret A; Jaśkiewicz A; Olma A; Leplawy MT; Rolka K
    Biochem Biophys Res Commun; 2006 Feb; 340(3):823-8. PubMed ID: 16380077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approach.
    Goswami R; Wohlfahrt G; Mukherjee S; Ghadiyaram C; Nagaraj J; Satyam LK; Subbarao K; Gopinath S; Krishnamurthy NR; Subramanya HS; Ramachandra M
    Bioorg Med Chem Lett; 2015 Feb; 25(3):616-20. PubMed ID: 25556099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity and inhibitory study of human airway trypsin-like protease.
    Wysocka M; Spichalska B; Lesner A; Jaros M; Brzozowski K; Łegowska A; Rolka K
    Bioorg Med Chem; 2010 Aug; 18(15):5504-9. PubMed ID: 20620066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase.
    Enyedy IJ; Lee SL; Kuo AH; Dickson RB; Lin CY; Wang S
    J Med Chem; 2001 Apr; 44(9):1349-55. PubMed ID: 11311057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors.
    Steinmetzer T; Dönnecke D; Korsonewski M; Neuwirth C; Steinmetzer P; Schulze A; Saupe SM; Schweinitz A
    Bioorg Med Chem Lett; 2009 Jan; 19(1):67-73. PubMed ID: 19036586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.